| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
|
| | | IP | CI | CM | Gabapentin Viatris 600 mg | 50 | 30.96 | 50.05 | 10 % | | Coated tablets: Gabapentinum 600 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G |  |
| | | IP | CI | CM | Gabapentin Viatris 600 mg | 100 | 58.30 | 79.75 | 10 % | | Coated tablets: Gabapentinum 600 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 800 mg | 50 | 40.96 | 60.90 | 10 % | | Coated tablets: Gabapentinum 800 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 800 mg | 100 | 77.26 | 100.35 | 10 % | | Coated tablets: Gabapentinum 800 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Sertralin Viatris | 10 | 5.83 | 15.60 | 10 % | | Coated tablets: Sertralinum 50 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Sertralin Viatris | 30 | 16.06 | 33.90 | 10 % | | Coated tablets: Sertralinum 50 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Sertralin Viatris | 100 | 61.45 | 83.25 | 10 % | | Coated tablets: Sertralinum 50 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 100 mg | 50 | 6.54 | 16.35 | 10 % | | Capsules: Gabapentinum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 100 mg | 100 | 11.51 | 28.95 | 10 % | | Capsules: Gabapentinum 100 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 300 mg | 50 | 14.12 | 31.75 | 10 % | | Capsules: Gabapentinum 300 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 300 mg | 100 | 28.22 | 47.10 | 10 % | | Capsules: Gabapentinum 300 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 400 mg | 50 | 20.31 | 38.45 | 10 % | | Capsules: Gabapentinum 400 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | CM | Gabapentin Viatris 400 mg | 100 | 38.30 | 58.05 | 10 % | | Capsules: Gabapentinum 400 mg | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| | | IP | CI | | Amisulpride Rivopharm 200 mg | 30 | PR | PR | k.A. | | Tablets: Amisulpridum 200 mg | Rivopharm SA | B | FB | | G | |
| | | IP | CI | | Amisulpride Rivopharm 200 mg | 90 | PR | PR | k.A. | | Tablets: Amisulpridum 200 mg | Rivopharm SA | B | FB | | G | |
| | | IP | CI | | Amisulpride Rivopharm 400 mg | 30 | PR | PR | k.A. | | compresse rivestite con film: Amisulpridum 400 mg | Rivopharm SA | B | FB | | G | |
| | | IP | CI | | Amisulpride Rivopharm 400 mg | 90 | PR | PR | k.A. | | compresse rivestite con film: Amisulpridum 400 mg | Rivopharm SA | B | FB | | G | |
| | | IP | CI | CM | Telfastin 120 | 10 | PR | PR | k.A. | | überzogene Tabletten: Fexofenadini Hydrochloridum 120 mg | Opella Healthcare
Switzerland AG | D | FB | | G | |
| | | IP | CI | CM | Telfastin 120 | 30 | PR | PR | k.A. | | überzogene Tabletten: Fexofenadini Hydrochloridum 120 mg | Opella Healthcare
Switzerland AG | D | FB | | G | |
| | | IP | CI | CM | Telfastin 180 | 10 | PR | PR | k.A. | | überzogene Tabletten: Fexofenadini Hydrochloridum 180 mg | Opella Healthcare
Switzerland AG | D | FB | | G | |
| L | | IP | CI | | Sifrol ER 0,375 mg | 10 Tablet(s) | 5.33 | 15.00 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 0,75 mg | 10 Tablet(s) | 9.85 | 27.05 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 0,75 mg | 30 Tablet(s) | 27.52 | 46.10 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 1,5 mg | 30 Tablet(s) | 55.03 | 75.75 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 3,0 mg | 30 Tablet(s) | 110.06 | 135.10 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| L | | IP | CI | | Sifrol ER 4,5 mg | 30 Tablet(s) | 165.09 | 194.45 | 10 % | | Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg | Boehringer Ingelheim
(Schweiz) GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Valtan-Mepha 80 mg | 28 Tablet(s) | 9.89 | 27.10 | 10 % | | Coated tablets: Valsartanum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Valtan-Mepha 80 mg | 98 Tablet(s) | 31.97 | 51.10 | 10 % | | Coated tablets: Valsartanum 80 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Valtan-Mepha 160 mg | 28 Tablet(s) | 11.91 | 29.30 | 10 % | | Coated tablets: Valsartanum 160 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Valtan-Mepha 160 mg | 98 Tablet(s) | 42.05 | 62.05 | 10 % | | Coated tablets: Valsartanum 160 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| L | | IP | CI | | Molaxole | 20 Sachet(s) | 5.44 | 15.15 | 10 % | | Pulver zum Einnehmen als Lösung: 4 Active Agents | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| L | | IP | CI | | Molaxole | 2 x 50 | 22.82 | 41.25 | 10 % | | Pulver zum Einnehmen als Lösung: 4 Active Agents | Viatris Pharma GmbH | B / SL / SG | FB | | G | |
| L | | IP | CI | | Norditropin FlexPro 15 mg | Set(s) | 512.24 | 573.50 | 10 % | | | Novo Nordisk Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | Cimzia | 2 syringe(s) | 891.98 | 986.50 | 10 % | | Injection solution: Certolizumabum Pegolum 200 mg/ml | UCB-Pharma SA | B / SL | FB | | G | |
| L | | IP | CI | | Norditropin FlexPro 5 mg | Set(s) | 171.06 | 202.45 | 10 % | | Injection preparation: Somatropinum Adnr 5 mg | Novo Nordisk Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | | Norditropin FlexPro 10 mg | Set(s) | 341.71 | 388.05 | 10 % | | Injection preparation: Somatropinum Adnr 10 mg | Novo Nordisk Pharma AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Revolade 12,5 mg | 14 | 249.49 | 287.75 | 10 % | | Coated tablets: Eltrombopagum 12.5 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Revolade 25 mg | 14 Tablet(s) | 498.97 | 559.10 | 10 % | | Coated tablets: Eltrombopagum 25 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Revolade 25 mg | 28 Tablet(s) | 997.94 | 1101.75 | 10 % | | Coated tablets: Eltrombopagum 25 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Revolade 50 mg | 14 Tablet(s) | 997.94 | 1101.75 | 10 % | | Coated tablets: Eltrombopagum 50 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | | IP | CI | PP | Revolade 50 mg | 28 Tablet(s) | 1995.87 | 2187.05 | 10 % | | Coated tablets: Eltrombopagum 50 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| L | | IP | | PP | Revolade 75 mg | 28 | 2993.81 | 3272.35 | 10 % | | Coated tablets: Eltrombopagum 75 mg | Novartis Pharma
Schweiz AG | A / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 5 mg | 30 Capsule(s) | 8.83 | 26.00 | 10 % | | Capsules: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 5 mg | 60 Capsule(s) | 15.53 | 33.30 | 10 % | | Capsules: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 10 mg | 30 Capsule(s) | 14.48 | 32.15 | 10 % | | Capsules: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | ● A+ / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 10 mg | 60 Capsule(s) | 25.48 | 44.15 | 10 % | | Capsules: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 20 mg | 30 Capsule(s) | 23.74 | 42.25 | 10 % | | Capsules: Oxycodoni Hydrochloridum 20 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | CI | A | Oxynorm 20 mg | 60 Capsule(s) | 41.78 | 61.85 | 10 % | | Capsules: Oxycodoni Hydrochloridum 20 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ / SL | FB | | G | |
| | | IP | | | Ropivacain Sintetica 5
mg/ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 5
mg/ml | 10 x 20 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 7.5
mg/ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 7.5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 7.5
mg/ml | 10 1 ampoule(s) à 20 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 7.5 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 10
mg/ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 10
mg/ml | 10 1 ampoule(s) à 20 ml | PR | PR | k.A. | | Injection solution: Ropivacaini Hydrochloridum 10 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Imipenem-Cilastatin-Mepha
i.v. | 10 | PR | PR | k.A. | | Lyophilisate: 2 Active Agents | Mepha Pharma AG | A | FB | | G | |
| | | IP | CI | | Belarina | 24 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gedeon Richter
(Schweiz) AG | B / LPPV | FB | | G | |
| | | IP | CI | | Belarina | 3 x 24 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gedeon Richter
(Schweiz) AG | B / LPPV | FB | | G | |
| | | IP | CI | | Belarina | 6 x 24 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Gedeon Richter
(Schweiz) AG | B / LPPV | FB | | G | |
| | | IP | CI | | Valtan-Mepha 40 mg | 28 Tablet(s) | 5.58 | 14.60 | k.A. | | Coated tablets: Valsartanum 40 mg | Mepha Pharma AG | B | FB | | G | |
| | | IP | CI | | Oxynorm 5 mg | 10 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Oxynorm 5 mg | 28 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Oxynorm 10 mg | 10 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Oxynorm 10 mg | 28 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Oxynorm 20 mg | 10 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 20 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | | Oxynorm 20 mg | 28 | PR | PR | k.A. | | Capsules: Oxycodoni Hydrochloridum 20 mg | Mundipharma Medical
Company, Hamilton,
Bermuda, Basel Branch | A+ | FB | | G | |
| | | IP | CI | A | Ketalgin 1 mg/ml | 1 l | PR | PR | k.A. | | Solution (oral): Methadoni Hydrochloridum 1 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | CI | A | Ketalgin 10 mg/ml | 1 l | PR | PR | k.A. | | Solution (oral): Methadoni Hydrochloridum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | CI | A | Ketalgin 10 mg/ml | 1 l | PR | PR | k.A. | | Solution (oral): Methadoni Hydrochloridum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | CI | A | Ketalgin 10 mg/ml | 3 l | PR | PR | k.A. | | Solution (oral): Methadoni Hydrochloridum 10 mg/ml | Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte | A+ | FB | | G | |
| | | IP | CI | | Molaxole | 100 Sachet(s) | 27.87 | 48.40 | k.A. | | Pulver zum Einnehmen als Lösung: 4 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Cleviprex | 10 1 Durchstechflasche(n) à 50 ml | PR | PR | k.A. | | emulsion pour perfusion: Clevidipinum | Chiesi SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | 10 1 ampoule(s) à 10 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | Sachet(s) à 100 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | 10 1 ampoule(s) à 20 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | Sachet(s) à 200 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | 10 1 Sachet(s) à 100 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | 5 1 Sachet(s) à 200 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
| | | IP | | | Ropivacain Sintetica 2
mg/ml | 5 x 500 ml | PR | PR | k.A. | | soluzione iniettabile o per infusione: Ropivacaini Hydrochloridum 2 mg/ml | Sintetica SA | B | FB | | G | |
